biosimulytics

🎆12 startups. Countless breakthroughs ahead. Japan, we’re ready. 🇯🇵✈️ We're absolutely thrilled to be one of just 12 startups selected for the EU-Japan Biotech Business Mission 2025, and we’re bringing our AI-powered tech to the heart of Asia’s $100B pharma market this October. 💊🌏 🧪 Our platform helps pharma R&D teams predict polymorph landscapes, accelerating timelines, reducing costs, and improving success rates. 🎯 Backed by the EIC - European Innovation Council, we’re now heading to BioJapan 2025 to meet with the region’s top biopharma players. Momentum is building, and we’re just getting started... #Biosimulytics #BioJapan2025 #PharmaTech #DeepTech #EUJapan #GlobalExpansion #AIinBiotech 👥 EU-Japan Centre for Industrial Cooperation

🎌 Big news coming🌏 When Japan calls, you don’t say no. More on that tomorrow. #StayTuned #Innovation #Japan #ComingSoon

The Innovation in HealthTech and Wellbeing Accelerator 2025 has been launched in collaboration with Enterprise Ireland’s Life Sciences and HealthTech team, Enterprise Ireland France, Crédit Agricole Creditor Insurance, La French Tech Dublin, the France-Ireland Chamber of Commerce, and The Digital Hub.   Two Enterprise Ireland companies, patientMpower and biosimulytics, have been selected to participate in a tailored one-week acceleration programme at Le Village by CA in Paris. The initiative will support their expansion in the French market through targeted investor meetings, partnership development, and customer engagement.   This pilot programme is designed to strengthen market access for Irish companies in the HealthTech and Wellbeing sectors, including Life Sciences, Digital Health, and SportsTech. Learn more https://shorturl.at/mutRo

We WON! 🥳 Biosimulytics is heading to Paris! 🇫🇷💥 We’re beyond excited to be named one of the two winners of the Innovation in Health Tech & Well-being Accelerator 2025 Challenge by Crédit Agricole Creditor Insurance (CACI)! Our mission to transform drug development using AI and deep tech is gaining momentum , and this incredible opportunity takes us one step closer to scaling our impact across Europe. 🌍 Massive thanks to CACI, La French Tech Dublin, France Ireland Chamber of Commerce, Enterprise Ireland, and all the amazing partners and supporters. We can’t wait to join the innovation ecosystem at Le Village by CA Paris! Let’s make health innovation happen. 💡🔥 #AIforHealth #DrugDiscovery #InnovationChallenge #FutureOfHealth #HealthTech #DeepTech #StartupsToWatch #ScalingScience #ParisHereWeCome

Today, most teams rely on trial-and-error lab work to uncover polymorphs. It’s slow. It’s limited. And it leaves critical blind spots. At Biosimulytics, we give teams a clearer view, earlier. Our platform simulates likely crystal structures and predicts their relative stability, helping teams anticipate polymorphic risk before it derails development. Think of it as radar for your pipeline. Less guesswork. More foresight. Smarter decisions. 📩 What could you build with fewer blind spots? #Biosimulytics #inSilico #Polymorphism #DrugDevelopment #PharmaInnovation #FormulationScience #AIinPharma #EarlyInsight #DeepTech #HPC

Polymorphism is one of the costliest risks in drug development. One molecule. Multiple crystal forms. Each can change stability, performance, and sometimes cause a drug to fail. 📉 Think it’s a small problem? Just ask Abbott. A late-forming polymorph of ritonavir once forced a recall, reformulation, and a loss of over $250 million. Or look at rotigotine, where an unanticipated polymorph disrupted a market-ready transdermal patch. At biosimulytics, we simulate likely crystal structures and predict their relative stability so formulation teams can assess polymorphic risks earlier in development. The result? Fewer blind spots. Faster insight. And far more confidence in every formulation decision. 📩 Want to see what you might be missing? Let's explore it together! #Biosimulytics #inSilico #Polymorphism #DrugDevelopment #PharmaInnovation #DeepTech #FormulationScience #AIinPharma #InvisibleRisks #PolymorphScreening

Developing medicines from new molecules is full of risks. One of the biggest? 🔍 Polymorphism: when a single drug molecule crystallizes in multiple forms. Each form can change how a drug dissolves, behaves, and holds up over time. The wrong form? 💸 Failed batches, regulatory delays, or worse -> treatments that never reach patients. That’s where we come in: 💻At biosimulytics we use advance simulation (physics + Viridien HPC, AI and Cloud) to predict crystal forms and identify which are most stable before they’re made in the lab. We help pharma teams: ✅ Reduce risk ✅ Reduce waste ✅ Save time ✅ Make better formulation decisions All from the earliest stages of developing treatments. 📬 Want to learn more about how in silico fits into your pipeline? Let’s talk. #Biosimulytics #inSilico #DrugDevelopment #PharmaInnovation #DeepTech #LifeSciences #Polymorphism

Two NovaUCD companies, Binarii Labs and biosimulytics, have reached the semi-final stage of the Start-Up World Cup at the Dublin Tech Summit. Fingers crossed for Aidan Finn and Peter F Doyle.

It’s day 2 of the Dublin Tech Summit! Make sure to stop by our booth for a chat about our cutting edge technology and innovative solutions.

Had the pleasure of attending the Annual Congress of Swiss Academy of Engineering Sciences SATW at FHNW Muttenz in Basel for biosimulytics. The focus this year — "Pharmaceutical Revolution: Artificial Intelligence and Quantum Technologies Driving Innovation" — was spot on. Fantastic sessions and even better conversations with experts from pharma, AI, and quantum computing. Many thanks to Peter Seitz for the kind invitation and the many useful introductions! #PharmaInnovation #AI #QuantumComputing #SATW #Biosimulytics #Networking #FutureOfPharma